ABSTRACT
Background and Objective@#The Philippines does not have a national congenital rubella syndrome (CRS) surveillance or registry. Regular monitoring of CRS cases in hospitals, including in a Philippine tertiary hospital, helped in the past to provide clinico-epidemiologic data on CRS. This study aimed to continue providing clinico-epidemiologic data on CRS cases seen in the Philippine tertiary hospital from 2009-2012 and 2019-2022 and compare the cases seen from said timelines.@*Methods@#A cross-sectional study was used, employing chart review of patients newly diagnosed with CRS from 2009-2012 and 2019-2022 in the Department of Ophthalmology and Visual Sciences at the Philippine tertiary hospital.@*Results@#Forty-two patients newly diagnosed with CRS from 2009-2012 and 2019-2022 were included. Only 14 (33%) were serologically-confirmed cases (albeit qualitatively). Median age (first and third interquartile ranges) at consult was 1 year (0.4, 2.5). Twenty-four (57%) patients had maternal history of rashes and/or fever. Trimester of pregnancy when mother became symptomatic was not significantly correlated with chief complaint (p=0.20) and numbers of ophthalmic (p=0.68) and systemic manifestations (p=0.32). Cataract was the most common ophthalmic manifestation present in 40 (95%) patients. Twenty-six (62%) patients had other associated systemic findings of which hearing loss was the most common. Only 29 of 40 patients with cataract underwent lensectomy, with 23 patients having poor visual prognosis prior to surgery (5 with nystagmus alone, 10 with nystagmus and strabismus, and 8 with strabismus alone). @*Discussion@#Using ophthalmic manifestations as primary indicator, this study provided an update on the CRS cases in the country. Laboratory confirmation remains a challenge in diagnosing CRS as the tests are costly and not widely available. There was increase from 2009-2012 compared to 2019-2022 in number of patients who underwent surgical treatment for cataract but visual outcomes were suboptimal due to delay in consultation. Although there was a decrease in number of CRS cases seen in the Philippine tertiary hospital, this cannot be attributed to increased rubella-containing vaccine (RCV) coverage alone. @*Conclusion@#Provision of data from individual hospital-based studies similar to this highlights the need for a national CRS surveillance system or registry. This can better gauge the burden of CRS and identify the gap in RCV coverage.
Subject(s)
Rubella Syndrome, Congenital , Retinitis PigmentosaABSTRACT
Background@#Infants with congenital rubella syndrome (CRS) often require multiple diagnostic procedures and interventions that include cataract surgery and procedures for congenital heart abnormalities. CRS is a vaccine preventable disease.@*Objective@#This study aimed to determine the costs incurred by the parents, Philippine Health Insurance Corporation (PHIC), hospital's medical social service (MSS), and non-governmental organization (NGO) in the management of CRS.@*Methods@#This is a costing study of five children diagnosed with probable CRS who were managed in a tertiary government hospital in Northern Luzon, Philippines. The parents or guardians of the patients were interviewed on the cost incurred particularly on non-medical related expenses during their outpatient department consultations and admissions. Hospital bills from our institutions and those from the previous institutions, if available, were retrieved. Expenses incurred from procedures or medical supplies relating to known complications of CRS were included in the computation.@*Results@#All five patients diagnosed with CRS had cardiac, ear, and eye manifestations. Two patients had postnatal complications. The average cost spent by the five patients' early years of life (mean age of patients was 16 ± 14 months) was ₱409,740.84. A quarter of the cost was out-of-pocket expenses while a third was covered by the hospital's MSS where the patients were seen. Another third was shouldered by an NGO. Most expenses were from the treatment of cardiac complications at 42% of the cost and had the highest average cost at ₱116,586.59. Case 1 had the highest financial cost at ₱833,514.24 mainly from the cardiac complications of CRS.@*Conclusion@#The cost of CRS in the early years of life is high. This is a significant financial burden to parents, PHIC, hospital's MSS, and NGO.
Subject(s)
Rubella Syndrome, Congenital , CataractABSTRACT
@#This is a case of a four-month-old female infant who presented with clinical manifestations of congenital rubella syndrome (CRS) — bilateral cataracts, poorly-dilating pupils, microcorneas, salt and pepper retinopathies seen after cataract extractions, bilateral sensorineural hearing loss, patent ductus arteriosus, microcephaly, history of blueberry spots and low birth weight, and positive serum IgM and IgG tests for rubella. The patient’s mother also had prenatal rubella infection. However, the patient also presented with additional set of clinical findings not seen in recent patients with CRS and not commonly reported in literature: visual acuities of poor to no dazzle, bilateral choroidal thickening on ocular ultrasound that spontaneously resolved, optic nerve inflammation that became atrophic, vessel tortuosities seen after cataract extractions, bilateral subependymal cysts with lenticulostriate vasculopathy in basal ganglia, basal ganglia hyperintensity suggestive of calcification, and jaundice. These findings plus the overlapping clinical manifestations with CRS and the positive IgM and IgG for cytomegalovirus (CMV) made us consider a congenital CMV co-infection. CRS already causes significant childhood morbidity. Getting co-infected with CMV in utero worsens morbidity and makes management more difficult. This case presented a congenital co-infection of rubella and CMV and discussed the added challenges in their diagnosis and management.
Subject(s)
Rubella Syndrome, Congenital , Cytomegalovirus Infections , CoinfectionABSTRACT
@#Congenital cytomegalovirus (CMV) infection (cCMV) is challenging to differentiate from congenital rubella syndrome (CRS) clinically. Virus detection and serological tests are needed. However, they are often not readily available or are expensive. This is a case of a five-month-old male with bilateral cataracts. He was jaundiced at birth and started having seizure episodes at one month of age. He was also diagnosed with right inguinal hernia and had abnormal bilateral hearing tests. Both eyes were noted to have leukocoria at two months of age. There was dazzle on both eyes and sclerae were anicteric. Examination revealed dense cataracts on both eyes, but their ocular ultrasound results were essentially normal. Due to the bilateral hearing loss and bilateral cataracts, CRS was initially considered despite the absence of heart abnormality since there were reported CRS cases without the complete triad. However, possible coinfection or another disease was considered due to the presence of jaundice, seizures, and hernia, which were never seen in our previous CRS patients nor were reported in the literature. The patient underwent cataract extraction on both eyes without intraocular lens implantation (IOL) as recommended for CRS cataracts to prevent severe inflammation. TORCH (TOxoplasmosis, Rubella, Cytomegalovirus, Herpes simplex) test was negative for rubella but positive for CMV. As such, the patient would have benefitted from early IOL implantation. The patient was then referred to a national medical center for possible treatment. However, since the patient already tested negative for CMV polymerase chain reaction (PCR) there, systemic antiviral therapy was no longer initiated. This case presented the challenge of clinically differentiating cCMV and CRS.
Subject(s)
Cytomegalovirus Infections , Rubella Syndrome, Congenital , Hearing Loss , JaundiceABSTRACT
@#Congenital rubella syndrome (CRS) cases being seen in a tertiary hospital in Baguio rose in 2020 during the COVID-19 pandemic. Its communicability presented logistical challenges to the hospital as additional contact and droplet precautions, including COVID-19 RT-PCR testing, were needed to be observed to prevent rubella transmission. The operations of the institute have also been disrupted and compromised since its space and resources were diverted to the pandemic response. A probable rubella transmission occurred when a patient with CRS was admitted for cataract surgery but was delayed due to the COVID-19 RT-PCR test requirement. Another patient admitted from the Outpatient Department on the same day developed maculopapular rashes for three days during admission but with no febrile episodes and lymphadenopathy. These cases showed how managing CRS cataracts got complicated by the current COVID-19 pandemic which resulted in the review and proposal to revise current hospital policies to minimize the exposure of vulnerable individuals and prevent future transmission.
Subject(s)
Rubella Syndrome, Congenital , Cataract , COVID-19ABSTRACT
Objetivo: analisar os casos de Síndrome da Rubéola Congênita notificados no Brasil durante o período de 1990 a 2016. Método: estudo transversal realizado no Brasil, cuja amostra foi de 122 casos notificados com Síndrome da Rubéola Congênita. Os dados foram disponibilizados pelo Departamento de Informática do Sistema Único de Saúde. A coleta de dados foi realizada durante os meses de fevereiro e março de 2021. O tratamento dos dados se deu por análise estatística uni-variada. Resultados: observa-se prevalência no Estado de São Paulo cuja capital apresentou o maior número destas notificações. O ano em que houve prevalência do diagnóstico foi em 2008 e o mês de maior notificação foi dezembro. Todos os pacientes apresentavam idade menor que um ano, sexo feminino, com confirmação final para a doença por meio de critérios laboratoriais, e evolução para a cura. Conclusão: a idade apresentou significância no estudo. A terapêutica mostrou-se eficiente para um melhor prognóstico de cura, bem como a vacinação como medida preventiva.(AU)
Objective: to analyze the cases of Congenital Rubella Syndrome notified in Brazil from 1990 to 2016. Method: cross-sectional study conducted in Brazil, whose sample consisted of 122 cases notified with Congenital Rubella Syndrome. Data were made available by the Departamento de Informática do Sistema Único de Saúde. Data collection was conducted during February and March 2021. The data were processed using univariate statistical analysis. Results: prevalence was observed in the state of São Paulo, whose capital city had the highest number of these notifications. The year in which there was prevalence of the diagnosis was 2008, and the month of greatest notification was December. All patients were less than one year old, female, with final confirmation of the disease through laboratory criteria, and progression to cure. Conclusion: Age was significant in this study. Therapy proved to be efficient for a better prognosis of cure, as well as vaccination as a preventive measure.(AU)
Objetivo: analizar los casos de Síndrome de Rubéola Congénita notificados en Brasil entre 1990 a 2016. Método: estudio transversal realizado en Brasil, cuya muestra fue 122 casos notificados con Síndrome de Rubéola Congénita. Los datos fueron facilitados por el Departamento de Informática del Sistema Único de Salud. La recogida de datos se realizó durante los meses de febrero y marzo de 2021. El tratamiento de los datos se realiza mediante un análisis estadístico univariante. Resultados: se observa una prevalencia en el Estado de São Paulo, cuya capital presenta el mayor número de notificaciones. El año y mes en que se produjo la prevalencia del diagnóstico fue 2008 y diciembre. Todos los pacientes presentaban una edad inferior a un año, sexo femenino, con confirmación final de la enfermedad mediante criterios de laboratorio y evolución para la cura. Conclusión: la edad presentó un significado en el estudio. El tratamiento es eficiente para un mejor pronóstico de curación, así como la vacunación como medida preventiva.(AU)
Subject(s)
Humans , Female , Infant , Rubella Syndrome, Congenital/epidemiology , Cross-Sectional Studies , Disease Notification , Rubella/prevention & control , Brazil , Health Information Systems/statistics & numerical dataABSTRACT
Resumen La rubeola es una enfermedad exantemática que se produce en la infancia. En caso de que se presente durante la gestación y hubiera afectación del producto, este puede desarrollar el síndrome de rubeola congénita, el cual incluye malformaciones cardiacas que se presentan en el 67% de los pacientes, de las cuales la más común es la persistencia del conducto arterioso, seguida de la estenosis valvular pulmonar y la comunicación interauricular. Se presenta el caso de un hombre de 20 años con diagnóstico de síndrome de rubeola congénita, quien desarrolló glaucoma congénito, insuficiencia aórtica grave, insuficiencia mitral grave y enfermedad miocárdica isquémica. Se realizó procedimiento quirúrgico de revascularización coronaria y recambio valvular mitral y aórtico. Los estudios encontrados durante el proceso de investigación mencionan el daño de los vasos sanguíneos y del miocardio producido por el virus. Con los datos obtenidos se corrobora la baja incidencia de presentación con compromiso coronario y valvular, por lo cual se hace énfasis en la importancia de este caso.
Abstract Rubella is an exanthematous disease that occurs in childhood. If it occurs during pregnancy and there is an effect on the product, it can develop congenital rubella syndrome. The congenital rubella syndrome includes cardiac malformations, which occur in 67% of patients, of which the most common is patent ductus arteriosus, followed by pulmonary valvular stenosis and atrial septal defect. We present the case of a 20-year-old man with a diagnosis of congenital rubella syndrome, presenting with congenital glaucoma, severe aortic insufficiency, severe mitral regurgitation and ischemic myocardial disease. In which a surgical procedure is performed by a coronary revascularization and mitral and aortic valve replacement. Studies found during the research process mention the damage to the blood vessels and myocardium produced by the virus. With the required data, the low incidence of presentation with coronary and valvular involvement is corroborated, which is why the importance of the present case is emphasized.
Subject(s)
Humans , Male , Young Adult , Congenital Abnormalities , Rubella Syndrome, Congenital , Aortic Valve Insufficiency , Ischemia , Mitral Valve InsufficiencyABSTRACT
A rubéola é uma doença viral, caracterizada como autolimitada e com evolução benigna,porém o fator de maior preocupação relacionado ao vírus da rubéola ocorre quando a infecção acomete gestantes, devido à capacidade que o vírus possui de causar infecção transpondo a barreira placentária podendo gerar a síndrome da rubéola congênita (SRC). Objetivo: O estudo pesquisou dados atualizados sobre a temática para advertir a população sobre os riscos relacionados à síndrome da rubéola congênita, além de contribuir com conhecimento científico de acadêmicos, profissionais da saúde e pesquisadores. Método: Para a elaboração do artigo de atualização, foi realizada uma revisão bibliográfica na ferramenta de busca Google Acadêmico, Sistema de Informação de Agravos de Notificação (SINAN), Ministério da Saúde e alguns livros, a fim de selecionar artigos e conteúdos disponíveis e atualizados para proporcionar maior compreensão do tema. Considerações Finais: O surgimento da vacina contra o vírus da rubéola foi uma grande conquista para a humanidade, uma vez que, após sua inclusão, houve uma redução significativa no número de casos novos de síndrome da rubéola congênita. Além disso, observou-se no decorrer da pesquisa uma grande dificuldade de encontrar trabalhos recém-publicados relacionados ao tema estudado
Rubella is viral disease, characterized as self-limiting and with a benign course, however the factor of greater concern related to rubella virus occurs when the infection affects pregnant women, due to the ability of the virus to cause infection by transposing the placental barrier, cangenerate the congenital rubella syndrome (CRS). Objective: The study searched update data on the subject to warn the population on related risks congenital rubella syndrome besides contributing with scientific knowledge of academics, health professionals and researchers. Method: For the elaboration of the update article, a bibliographic review was carried out in the Google Scholar search tool, the Notification of Injury Information System (SINAN), the Ministry of Health and some books, in order to select articles and contents available and update to provide understanding of the theme. Final considerations: The emergence of the rubella virus vaccine was great achievement for mankind, since after its inclusion there was a significant a reduction in the number of new cases of congenital rubella syndrome. In addition, it was observed during the research a great difficulty to find recently published papers related to the subject studied
Subject(s)
Congenital Abnormalities , Rubella Syndrome, Congenital/diagnosis , Rubella Syndrome, Congenital/physiopathology , Rubella Syndrome, Congenital/prevention & control , Rubella Syndrome, Congenital/therapy , Rubella Syndrome, Congenital/transmission , Rubella Syndrome, Congenital/epidemiology , Virus DiseasesABSTRACT
Rubella or German measles is an infection caused by rubella virus (RV). Infection of children and adults is usually characterized by a mild exanthematous febrile illness. However, RV is a major cause of birth defects and fetal death following infection in pregnant women. RV is a teratogen and is a major cause of public health concern as there are more than 100,000 cases of congenital rubella syndrome (CRS) estimated to occur every year. Several lines of evidence in the field of molecular biology of RV have provided deeper insights into the teratogenesis process. The damage to the growing fetus in infected mothers is multifactorial, arising from a combination of cellular damage, as well as its effect on the dividing cells. This review focuses on the findings in the molecular biology of RV, with special emphasis on the mitochondrial, cytoskeleton and the gene expression changes. Further, the review addresses in detail, the role of apoptosis in the teratogenesis process.
Subject(s)
Humans , Female , Pregnancy , Pregnancy Complications, Infectious/virology , Rubella/complications , Rubella virus/physiology , Congenital Abnormalities/virology , Rubella Syndrome, Congenital/virology , Teratogenesis , Rubella/virology , Virus Replication/physiology , Signal Transduction , Apoptosis/physiology , Mitochondria/virologyABSTRACT
Estos protocolos están dirigido a personal médico, paramédico y otros profesionales que realizan acciones gerenciales y operativas de vigilancia epidemiológica en los servicios de salud del país, y están divididos en varios tomos para dar a conocer y actualizar la identificación y medidas de control para diversos padecimientos a fin de continuar con el mejoramiento de las capacidades técnicas de los trabajadores de salud, que permita planificar la prestación de servicios con decisiones partiendo de un enfoque epidemiológico comprobado, para responder a los cambios de tendencias epidemiológicas y con ello contribuir al fortalecimiento de prácticas asertivas de la salud pública de nuestro país. La vigilancia epidemiológica de las enfermedades prevenibles con vacuna, busca reducir la mortalidad y morbilidad por infecciones inmunoprevenibles. La vigilancia epidemiológica, es fundamental para evaluar el impacto de las intervenciones y la toma de decisiones de acuerdo al análisis permanente de la situación de salud.
Subject(s)
Humans , Male , Female , Pregnancy , Infant, Newborn , Infant , Child, Preschool , Adolescent , Adult , Poliomyelitis/prevention & control , Rubella virus , Tuberculosis, Meningeal/prevention & control , Rubella Syndrome, Congenital/prevention & control , Diphtheria/prevention & control , Epidemiological Monitoring , Measles/prevention & control , Tetanus/prevention & control , Health Surveillance/organization & administration , Whooping Cough/prevention & control , Health Surveillance System , GuatemalaABSTRACT
RESUMEN Objetivo Determinar la seroprevalencia de anticuerpos IgG anti-rubéola y anti-citomegalovirus en un grupo de mujeres entre 16 y 40 años, residentes en Tunja. Métodos Investigación descriptiva de corte transversal, en la cual se incluyeron mujeres de 16 a 40 años, por medio de un muestreo no probabilístico por conveniencia. Las variables sociodemográficas fueron registradas mediante encuesta. Se empleó ensayo inmunoenzimático para la determinación cuantitativa de anticuerpos IgG frente a rubéola y citomegalovirus en suero. La estadística aplicada al estudio se llevó a cabo por medio del programa estadístico SPSS versión 21. Resultados El estudio incluyó un total de 154 mujeres en edad fértil, estableciéndose una seropositividad para IgG anti-rubéola de 96,1% (n=148) (IC 95% 93,0 - 99,1) y anti-citomegalovirus de 90,9% (n=140) (IC 95% 86,3 - 95,4). Conclusión Una de cada diez mujeres en estudio está en riesgo de adquirir una infección primaria por citomegalovirus y una de cada 30 por rubéola. El control prenatal por medio de determinaciones serológicas frente a citomegalovirus y rubéola durante el embarazo es primordial en estos casos.(AU)
ABSTRACT Objective To determine the seroprevalence of anti-rubella and anti-cytomegalovirus IgG antibodies in a group of women aged between 16 and 40 years, residents of Tunja. Methods Descriptive, cross-sectional research in women aged between 16 and 40 years included by means of non- probability sampling for convenience. Sociodemographic variables were recorded by applying a survey. An enzyme immunoassay was used for the quantitative determination of rubella and cytomegalovirus IgG antibodies in serum. The statistical analysis was carried out using the statistical program SPSS version 21. Results The study included 154 women of childbearing age, establishing seropositivity for anti-rubella IgG of 96.1% (n=148) (95%CI: 86.3 - 95.4) Conclusion One in ten women included in the study is at risk of primary cytomegalo-virus infection and one in 30 of rubella infection. Prenatal care using serological determinations of cytomegalovirus and rubella during pregnancy is essential in these cases.(AU)
Subject(s)
Humans , Female , Pregnancy , Prenatal Diagnosis/methods , Rubella Syndrome, Congenital/immunology , Cytomegalovirus Infections/immunology , Antibodies, Viral , Seroepidemiologic Studies , Epidemiology, Descriptive , Cohort StudiesABSTRACT
Resumen En la presente revisión se ofrecen las pautas éticas que rigen el esquema con que debe ser aplicada la vacuna triple contra Sarampión Rubeola y Paperas. Se hace énfasis en la falta de datos clínicos que hayan asociado esta vacuna con el desarrollo de autismo en niños y se expone con base en evidencia científica los riesgos de la no vacunación en este grupo etario.
Abstract In the present review is offered the ethical guidelines that govern the scheme with which the triple vaccine against Measles Rubella and Mumps must to be applied. It emphasizes the lack of clinical data that have associated this vaccine with the development of autism in children and exposes based on scientific evidence the risks of non-vaccination in this age group.
Subject(s)
Rubella/drug therapy , Autistic Disorder , Vaccination/adverse effects , Measles-Mumps-Rubella Vaccine/analysis , Measles/drug therapy , Mumps/drug therapy , Rubella Syndrome, Congenital , Immunization Programs , Costa RicaABSTRACT
En esta edición, se expondrán fundamentalmente los casos de sarampión confirmados de la Ciudad. Ante la circulación del virus de sarampión en países de América y el resto del mundo, la importación de casos es actualmente la forma de entrada del mismo al país y la Ciudad. Se deberá tener en cuenta que la Ciudad de Buenos Aires no presenta casos autóctonos desde 1999 y que confluyen en el momento actual varios factores que pueden desencadenar un brote ante la introducción de un caso: el incremento de susceptibles; la vigilancia cuya tasa de detección, durante varios años, no llegó a la establecida internacionalmente; bajas coberturas de vacunación y que la Ciudad representa el punto más importante del país para la entrada y salida de turistas hacia y desde otros países del mundo. La principal medida para evitar la reintroducción y diseminación del virus del sarampión y la rubéola es sin duda la vacunación de la población susceptible; ésta, junto a un sistema de vigilancia (clínica y de laboratorio) de alta calidad y suficientemente sensible son los pilares para impedir la producción de brotes relacionados con la importación y mantener eliminada esta enfermedad. El sistema de Vigilancia cumple el rol fundamental: detectar oportunamente los casos sospechosos a fin de accionar de manera rápida y efectiva.
Subject(s)
Rubella Syndrome, Congenital/prevention & control , Rubella Syndrome, Congenital/epidemiology , Disease Notification , Health Surveillance System , Fever/prevention & control , Fever/epidemiology , Measles/diagnosis , Measles/prevention & control , Measles/epidemiology , Measles/virologyABSTRACT
Introducción: 1 a 2 de cada 1.000 recién nacidos tienen una pérdida auditiva neurosensorial significativa. De las deficiencias auditivas congénitas, el 50% resultan de infecciones en el embarazo y/o parto; como las provocadas por: Toxoplasmosis, rubéola, citomegalovirus, herpes y sífilis. Métodos: Se realizó una búsqueda bibliográfica sistemática de artículos utilizando bibliotecas virtuales y libros de texto de relevancia dentro de la especialidad. Resultados: La rubéola en mujeres susceptibles puede producir el síndrome de rubéola congénita. La sordera es la manifestación más frecuente de la enfermedad y es la secuela más importante. El 15% de los niños infectados por Citomegalovirus padecen una pérdida auditiva por daño coclear y alteraciones en el sistema nervioso central al nacer. Otro 15% pueden desarrollar luego del nacimiento hipoacusia, retardo mental o dificultades en el desarrollo del lenguaje y del aprendizaje. Aproximadamente el 80% de los recién nacidos infectados por toxoplasmosis son asintomáticos; el resto presentará manifestaciones clínicas de afectación sistémica incluyendo compromiso auditivo como parte del cuadro. La infección por Herpes simple suele ser devastadora en el recién nacido. Se ha descrito hipoacusia en más del 50% de los casos. La sordera se asocia frecuentemente con la sífilis congénita. Junto con la queratitis intersticial y las malformaciones dentarias, forma parte de la tríada de Hutchinson. Conclusiones: La hipoacusia es un problema de gran importancia en la infancia. Las infecciones agrupadas en el término TORCHS causan hipoacusia neurosensorial adquirida en forma prenatal, dando lugar a sorderas presentes al nacer o de desarrollo diferido o progresivo.
Introduction: 1 to 2 of every 1,000 newborns have significant sensorineural hearing loss. From all the congenital hearing empairments, 50% take place during pregnancy and/or childbirth; such as those caused by: toxoplasmosis, rubella, cytomegalovirus, herpes and syphilis. Methods: A systematic literature research was performed using virtual libraries and relevant specialty textbooks. Results: Rubella in susceptible women may cause congenital rubella syndrome. Deafness is the most common manifestation of the disease and is the most important sequel. 15% of those children infected with Cytomegalovirus children suffer hearing loss from cochlear damage and alterations in the central nervous system at birth. Another 15% can then develop birth hearing loss, mental retardation or difficulties in language development and learning. Approximately 80% of newborns infected with toxoplasmosis are asymptomatic; the rest will present clinical manifestations of systemic disease including hearing impairment as part of the picture. Herpes simplex infection is devastating in the new born. Hearing loss has been described in over 50% of cases. Deafness is often associated with congenital syphilis. Along with interstitial keratitis and dental malformations, it is part of the Hutchinson triad. Conclusions: Hearing loss is a major problem in childhood. Gathered as TORCHS acquired infections cause sensorineural hearing loss prenatally, resulting in hearing loss present at birth or deferred or progressive development.
Introdução: 1 a 2 em cada 1.000 recém-nascidos têm perda auditiva neurossensorial significativo. Das deficiências auditivas congênitas, 50% das infecções resultar em gravidez e / ou parto; tais como aquelas causadas por: toxoplasmose, rubéola, citomegalovírus, herpes e sífilis. Métodos: Uma busca sistemática da literatura foi realizada utilizando bibliotecas virtuais e livros relevantes no art. Resultados: A rubéola em mulheres suscetíveis pode causar a síndrome da rubéola congênita. A surdez é a manifestação mais comum da doença e é a sequela mais importante. 15% das crianças infectadas com Citomegalovírus sofrer perda de audição de danos e alterações coclear no sistema nervoso central no nascimento. Outros 15% podem desenvolver perda auditiva nascimento, retardo mental ou dificuldades no desenvolvimento da linguagem e aprendizagem. Cerca de 80% dos recém-nascidos infectados com toxoplasmose é assintomática; o resto vai apresentar manifestações clínicas da doença sistêmica, incluindo a deficiência auditiva como parte da imagem. Infecção Herpes simplex geralmente devastadores no recém-nascido. A perda de audição tem sido descrita em mais de 50% dos casos. A surdez é frequentemente associada a sífilis congênita. Junto com ceratite intersticial e malformações dentárias, faz parte da tríade Hutchinson. Conclusões: A perda auditiva é um problema grave na infância. Agrupados nas infecções TORCHS causam perda auditiva neurossensorial pré-natal, resultando em perda auditiva presente no nascimento ou em diferido ou desenvolvimento progressivo.
Subject(s)
Humans , Hearing Loss, Sensorineural/etiology , Hearing Loss, Sensorineural/prevention & control , Cytomegalovirus Infections/complications , Herpes Simplex/complications , Prenatal Injuries/etiology , Rubella Syndrome, Congenital/complications , Syphilis, Congenital/complications , Toxoplasmosis, Congenital/complicationsABSTRACT
Congenital rubella syndrome (CRS), an important cause of severe birth defects, remains a public health problem in a significant number of countries. Therefore, global health experts encourage use of rubella vaccination, with the primary aim of preventing CRS. While large-scale rubella vaccination during the last decade has drastically reduced or eliminated both the virus and CRS in Europe and the Americas, many countries in Africa, South-East Asia, the Eastern Mediterranean, and the Western Pacific have not yet incorporated any type of rubella-containing vaccine into their immunization schedule. As a result, through travel and migration, rubella has been imported into countries that had successfully eliminated the virus, leading to outbreaks and the reestablishment of endemic transmission. The objective of this study was to identify the key factors required for CRS elimination (prevalence reduction, vaccination strategies, and surveillance methods) by reviewing publications in PubMed on rubella and CRS (systematic reviews, country experiences, and position papers from the World Health Organization (WHO) and other intergovernmental organizations). Based on the results of the review, to eliminate rubella and CRS in endemic areas and reduce re-emergence in previously disease-free areas, all countries should carry out two types of mass rubella vaccination campaigns: 1) one single mass national immunization campaign targeting all men and women 5-39+ years old (with the upper age limit depending on the year in which the rubella-containing vaccine was introduced and the epidemiology of rubella in the country) and 2) incorporation of an rubella-containing vaccine in routine childhood immunization programs, including regular vaccination campaigns for 12-month-olds and measles follow-up campaigns. In addition to mass rubella immunization campaigns and routine childhood vaccination programs, the following measures should be taken to help fight rubella and CRS: 1) surveillance of the number of susceptible women of childbearing age, and the emergence of imported cases; 2) coverage of susceptible populations with "second-chance" ("catch-up") campaigns (vaccination of older children and adults who may have missed earlier immunization programs); 3) rapid response to outbreaks; 4) strengthening of CRS surveillance; 5) involvement of the private sector in awareness and vaccination campaigns; and 6) reduction of the number of false-positive laboratory test results.
El síndrome de rubéola congénita (SRC), una causa importante de defectos congénitos graves, sigue siendo un problema de salud pública en un número significativo de países. Por consiguiente, los expertos mundiales en salud promueven el uso de la vacunación antirrubeólica con el objetivo primario de prevenir el SRC. Aunque, durante el último decenio, la vacunación antirrubeólica administrada a gran escala ha reducido drásticamente o eliminado tanto el virus como el SRC en Europa y la Región de las Américas, muchos países de África, Asia Sudoriental, el Mediterráneo Oriental y el Pacífico Occidental aún no han incorporado ningún tipo de vacuna con componente antirrubeólico en su calendario de vacunaciones. Como resultado, y a consecuencia de los viajes y las migraciones, la rubéola se ha importado a países que habían eliminado eficazmente el virus, provocando brotes y el restablecimiento de la transmisión endémica. El objetivo de este estudio fue determinar los factores clave requeridos para la eliminación del SRC (reducción de la prevalencia, estrategias de vacunación y métodos de vigilancia) mediante la revisión de publicaciones aparecidas en PubMed sobre la rubéola y el SRC (revisiones sistemáticas, experiencias de países y documentos de posición de la Organización Mundial de la Salud y otras organizaciones intergubernamentales). Con base en los resultados de la revisión, y con objeto de eliminar la rubéola y el SRC en las zonas endémicas y reducir su reaparición en las zonas previamente libres de la enfermedad, todos los países deben llevar a cabo dos tipos de campañas de vacunación antirrubeólica masivas: 1) una única campaña de vacunación masiva a escala nacional dirigida a todos los hombres y mujeres de 5 a 39 años de edad (el límite superior de edad depende del año de introducción de la vacuna con componente antirrubeólico y de la epidemiología de la rubéola en el país), y 2) la incorporación de una vacuna con componente antirrubeólico en los programas sistemáticos de vacunación infantil, incluidas las campañas regulares de vacunación dirigidas a lactantes de 12 meses de edad y las campañas de seguimiento de las enfermedades exantemáticas. Además de las campañas de vacunación masiva contra la rubéola y los programas sistemáticos de vacunación infantil, se deben aplicar las siguientes medidas para ayudar a combatir la rubéola y el SRC: 1) la vigilancia de las mujeres en edad fecunda susceptibles, y de la aparición de casos importados; 2) la cobertura de las poblaciones vulnerables mediante campañas de "segunda oportunidad" ("puesta al día") (vacunación de niños mayores y adultos a los que no hubieran alcanzado los programas de vacunación anteriores); 3) la respuesta rápida ante los brotes; 4) el fortalecimiento de la vigilancia del SRC; 5) la participación del sector privado en las campañas de concientización y vacunación; y 6) la reducción del número de resultados de pruebas de laboratorio falsamente positivos.
Subject(s)
Rubella Syndrome, Congenital/complications , Rubella Syndrome, Congenital/diagnosis , Rubella Syndrome, Congenital/prevention & control , Rubella Syndrome, Congenital/transmissionABSTRACT
Introdução: A rubéola é uma doença exantemática aguda, de origem viral. Sua transmissão ocorre por meio de contato de secreções de vias aéreas de pessoas infectadas ou por transmissão vertical. A síndrome da rubéola congênita (SRC) ocorreem função de infecção materna, durante os três primeiros meses de gestação, quando pode haver a invasão da placenta pelo vírus, com disseminação pelos tecidos embrionários, acarretando aborto espontâneo, natimortos e efeitos congênitos. A determinação dos anticorpos IgG e IgM específicos são muito importantes para o diagnóstico sorológico das infecções pela rubéola congênita pós-natal ou primária. O tratamento é relativo aos sintomas apresentados e o período de gestação da mãe. A vacinação é o procedimentomais eficaz, onde se adquire a munidade, que é duradoura. Objetivos: Verificar a prevalência de rubéola nos pacientes atendidos na Unidade Básica de Saúde (UBS), em Campo Bom, no Rio Grande do Sul (RS), e examinar os fatores de risco da doença e susceptibilidade na população estudada. Metodologia: Estudo transversal, utilizando dados de 94 pacientes atendidos na UBS, em Campo Bom (RS), entre maio de 2005 e maio de 2009. Para a realização dos testes, foram coletadas 5 mL de sangue periféricocom o paciente em jejum. Utilizou-se soro para dosar IgG e IgM antirrubéola, através do teste de ELISA. As amostras foram processadas no Laboratório de Biomedicina do Centro Universitário Feevale, em Novo Hamburgo (RS). Resultados: Dos 94 pacientes com faixa etária dos 2 aos 51 anos, 87 (92,5%) eram do sexo feminino, sendo que, 15destes (17,2%) estavam em período gestacional e 7 (7,4%) eram do sexo masculino. Dos pacientes analisados, 89 (94%) apresentaram IgG positivo. Conclusão: O presente estudo demonstrou que a população avaliada pode ter adquirido imunidade através deinfecção primária ou por vacinação, diminuindo, dessa maneira, o contágio nos grupos de risco
Introduction: Rubella is an acute exanthematous disease of viralorigin. It is transmission occurs through contact of airway secretionsof infected people or by vertical transmission. The congenital rubellasyndrome (CRS) occurs due to maternal infection during the first 3months of pregnancy, can occur when the invasion of the placentaby the virus to spread by the embryonic tissues, leading tomiscarriage, stillbirth and birth defects. The determination of IgGand IgM specific are very important for the serological diagnosis ofcongenital rubella infection by postnatal or primary. The treatmentis on the symptoms and the gestation period of the mother. Sincethe vaccination the most effective procedure, which is acquiredimmunity, which is long lasting. Objectives: To assess theprevalence of rubella in patients enrolled in the Basic Health Unitin Campo Bom, Rio Grande do Sul (RS). To examine the riskfactors and disease susceptibility in the population. Methodology:Cross-sectional study using data from 94 patients treated in theBasic Health Unit in Campo Bom (RS) between May 2005 and May2009. For the tests, were collected 5 mL of peripheral blood withthe patient fasting, serum was used for measuring rubella IgG andIgM by ELISA. The samples were processed at the Laboratory ofBiomedicine in the Feevale University Center in Novo Hamburgo(RS). Results: Of 94 patients, aged from 2 to 51, 87 (92.5%) werefemale, and 15 of these (17.2%) are in the gestational period and 7(7.4%) is male. Of the patients studied, 89 (94%) had positive IgGwhich could mean the effectiveness of public awareness of theneed for prevention of rubella. Conclusion: This studydemonstrates that the study population may have acquired immunitythrough primary infection or through vaccination, decreasing thespread of disease in risk groups.
Subject(s)
Humans , Male , Female , Adolescent , Young Adult , Middle Aged , Enzyme-Linked Immunosorbent Assay , Prevalence , Rubella , Rubella Syndrome, CongenitalABSTRACT
Antecedentes: Costa Rica estableció la meta de eliminación del síndrome de rubéola congénita desde el año 2000. Datos oficiales de vigilancia reportan el último caso autóctono confirmado en el 2001. Para evaluar si se logró la meta de eliminación de la enfermedad se analizó, mediante una búsqueda retrospectiva, la calidad de la vigilancia del síndrome para determinar la existencia de casos que no fueron capados por el sistema vigente...
Subject(s)
Humans , Infant, Newborn , Infant , Rubella Syndrome, Congenital/diagnosis , Costa RicaABSTRACT
BACKGROUND: Congenital rubella syndrome (CRS) case identification is challenging in older children since laboratory markers of congenital rubella virus (RUBV) infection do not persist beyond age 12 months. METHODS: We enrolled children with CRS born between 1998 and 2003 and compared their immune responses to RUBV with those of their mothers and a group of similarly aged children without CRS. Demographic data and sera were collected. Sera were tested for anti-RUBV immunoglobulin G (IgG), IgG avidity, and IgG response to the 3 viral structural proteins (E1, E2, and C), reflected by immunoblot fluorescent signals. RESULTS: We enrolled 32 children with CRS, 31 mothers, and 62 children without CRS. The immunoblot signal strength to C and the ratio of the C signal to the RUBV-specific IgG concentration were higher (P < .029 for both) and the ratio of the E1 signal to the RUBV-specific IgG concentration lower (P = .001) in children with CRS, compared with their mothers. Compared with children without CRS, children with CRS had more RUBV-specific IgG (P < .001), a stronger C signal (P < .001), and a stronger E2 signal (P ≤ .001). Two classification rules for children with versus children without CRS gave 100% specificity with >65% sensitivity. CONCLUSIONS: This study was the first to establish classification rules for identifying CRS in school-aged children, using laboratory biomarkers. These biomarkers should allow improved burden of disease estimates and monitoring of CRS control programs. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.
Subject(s)
Schools , Students , Rubella Syndrome, Congenital/diagnosis , Biomarkers/blood , Adolescent , Antibodies, Viral , Antibody AffinityABSTRACT
As mulheres em idade reprodutiva são a população de maior interesse para a prevenção da síndrome da rubéola congênita. O objetivo do trabalho foi avaliar a prevalência de vacinação contra rubéola em mulheres e identificar fatores associados e motivos da não adesão. Trata-se de estudo transversal de base populacional, realizado em Campinas, São Paulo, Brasil, em 2008/2009, com amostra por conglomerados e em dois estágios. Das 778 mulheres de 10 a 49 anos, 83,8% (IC95%: 79,6-88,0) referiram vacinação em algum momento da vida. Faixa etária (30-39 anos), renda familiar per capita superior a três salários mínimos e a orientação de profissional de saúde estiveram positivamente associadas à vacinação contra a rubéola. Os principais motivos da não adesão foram a falta de orientação do profissional de saúde sobre sua importância (48,5%) e não considerá-la necessária (18,9%). A recomendação do profissional de saúde foi o fator mais fortemente associado à adesão das mulheres à vacinação. Nesse sentido, sua indicação pelas equipes de saúde pode ampliar o conhecimento sobre sua importância e seus benefícios.
Women of reproductive age are the population of greatest interest for the prevention of congenital rubella syndrome. The aim of this study was to evaluate the prevalence of rubella vaccination in women and to identify factors associated and motives for non-adherence. A cross-sectional population-based study, in Campinas, São Paulo State, Brazil, in 2008/2009, was carried out with stratified random, two-stage cluster sampling. Of the 778 women aged 10 to 49 years, 83.8% (95%CI: 79.6-88.0) reported vaccination in life. Age group (20-39 years), per capita household income greater than 3 times the minimum wage and orientation of health care professionals about the vaccine, were positively associated with rubella vaccination. The main motives for non-adherence were lack of orientation of professionals about their importance (48.5%) and not consider it necessary (18.9%). The recommendation of professionals was the factor most strongly associated with women's adherence to vaccination. In this sense, an indication of vaccination by health care teams can increase the knowledge about the importance their and benefits.
Las mujeres en edad reproductiva son la población de mayor interés para la prevención del síndrome de la rubeola congénita. El objetivo del trabajo fue evaluar la prevalencia de vacunación contra la rubeola en mujeres e identificar factores asociados y motivos de la no adhesión al programa de vacunación. Se trata de un estudio transversal de base poblacional, realizado en Campinas, São Paulo, Brasil, en 2008/2009, con una muestra por conglomerados y en dos fases. De las 778 mujeres, de 10 a 49 años, un 83,8% (IC95%: 79,6-88,0) informaron de vacunación en algún momento de la vida. La franja de edad (30-39 años), renta familiar per cápita superior a tres salarios mínimos y la orientación de un profesional de salud estuvieron positivamente asociadas a la vacunación contra la rubeola. Los principales motivos de la no adhesión fueron la falta de orientación del profesional de salud sobre su importancia (48,5%) y no considerarla necesaria (18,9%). La recomendación del profesional de salud fue el factor más fuertemente asociado a la adhesión de las mujeres a la vacunación. En este sentido, su indicación por los equipos de salud puede ampliar el conocimiento sobre su importancia y sus beneficios.
Subject(s)
Adolescent , Adult , Child , Female , Humans , Middle Aged , Young Adult , Vaccination Coverage , Mass Vaccination , Rubella Syndrome, Congenital/prevention & control , Rubella Vaccine/administration & dosage , Brazil , Cross-Sectional Studies , Health Knowledge, Attitudes, Practice , Mass Vaccination/statistics & numerical data , Poisson Distribution , Socioeconomic Factors , Urban PopulationABSTRACT
PURPOSE: We report a case of congenital rubella syndrome with bilateral zonular cataracts. CASE SUMMARY: A 69-year-old man visited the hospital with visual disturbance in both eyes. His mother had been diagnosed with rubella during pregnancy, exhibiting typical fever and rashes. His visual acuity and hearing ability had been poor since birth. Corrected visual acuity was 0.3 in the right eye and 0.4 in the left eye. Slit lamp examination revealed bilateral zonular cataracts. On pure tone audiometry test, pure tone hearing threshold was 73 dB in the right ear and 72 dB in the left ear, corresponding to severe hearing loss in both ears. Echocardiogram showed a 1.5 cm-sized ostium secundum atrial septal defect, causing atrial fibrillation. Laboratory workup revealed an extremely high level of IgG antibody (titer = 1:301), and negative IgM antibody. A rubella IgG avidity test was 95.5%, suggesting remote rubella infection. Chromosomal analysis from peripheral blood did not show any abnormalities. The patient was diagnosed with congenital rubella syndrome with bilateral zonular cataracts. Two months after cataract surgery on both eyes, visual acuity steadily improved to 1.0 in both eyes. CONCLUSIONS: Congenital rubella syndrome is comprised of physical abnormalities such as sensorineural hearing loss, eye defects including congenital cataract, and cardiovascular defects due to gestational rubella infection. The possibility of congenital rubella syndrome should be considered even in old age, and a systemic multi-organ approach is necessary for therapeutic planning.